Pfizer Inc. (BVL:PFE)

Market Cap	498.25B
Revenue (ttm)	219.64B
Net Income (ttm)	34.38B
Shares Out	n/a
EPS (ttm)	6.04
PE Ratio	14.49
Forward PE	8.75
Dividend	6.14 (23.44%)
Ex-Dividend Date	Nov 7, 2025

Volume	20
Average Volume	779
Open	n/a
Previous Close	26.18
Day's Range	n/a
52-Week Range	21.09 - 28.50
Beta	n/a
RSI	71.45
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Lima Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD